C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 491/048 (2006.01) A61K 31/4741 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01) A61P 43/00 (2006.01) C07D 491/04 (2006.01)
Patent
CA 2512765
A drug that is useful for treating schizophrenia. In particular, a therapeutic agent for schizophrenia comprising as an active ingredient a 4-acylamino- 5,6,7,8-tetrahydrofuro[2,3-b]quinoline derivative, or its optical enantiomorph or acid adduct salt, or a hydrate or solvate thereof.
L'invention concerne un médicament utile pour le traitement de la schizophrénie, et en particulier un agent pour ce traitement qui comprend comme principe actif un dérivé de 4-acylamino-5,6,7,8-tétrahydrofuro[2,3-b]quinoline, ou son énantiomorphe optique ou sel d'addition d'acide, ou bien un hydrate ou un solvate correspondant.
Bessho Tomoko
Takashina Ken
Kirby Eades Gale Baker
Mitsubishi Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Therapeutic agent for schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for schizophrenia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1741768